John D. Groarke
0000-0002-5277-8696
Publication & Citation Trends
Most Cited Works
Publications
136 total
Efficacy and safety of ponsegromab in patients with colorectal cancer and cachexia: A subgroup analysis of the PROACC-1 phase 2 study.
Cited by 0
Semantic Scholar
LBA102 Efficacy and safety of ponsegromab in patients with cancer-associated cachexia: Results from the open-label extension of a randomized, placebo-controlled, phase II study
Cited by 0
Semantic Scholar
Baseline circulating growth differentiation factor-15 and the cancer phenotype in the PROACC-1 phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia.
Cited by 0
Semantic Scholar
Association between growth differentiation factor-15 and adverse outcomes among patients with heart failure: A systematic literature review OA
Cited by 8
Semantic Scholar
Estimating adult cancer cachexia prevalence and impact on survival in the US: Real-world data analysis.
Cited by 0
Semantic Scholar
LBA82 Efficacy and safety of ponsegromab, a first-in-class, monoclonal antibody inhibitor of growth differentiation factor 15, in patients with cancer cachexia: A randomized, placebo-controlled, phase II study
Cited by 0
Semantic Scholar
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society PDF
Cited by 737
OpenAlex
Research Topics
Chemotherapy-induced cardiotoxicity and mitigation
(26)
Cardiac Imaging and Diagnostics
(23)
Heart Failure Treatment and Management
(22)
Cardiovascular Function and Risk Factors
(17)
Nutrition and Health in Aging
(14)
Frequent Co-Authors
Affiliations
Boston University
Indiana University Health
Brigham and Women's Hospital
Fundación Juan March
St. Luke's-Roosevelt Hospital Center